Enacting Business Translation: Implementing a Digital Interaction Assessment Scheme in Reality
A biopharmaceutical company, specializing in the development and commercialization of novel therapeutics for rare cancers, partnered with Clarkston to revolutionize its digital engagement measurement strategies. The company was grappling with siloed reports from multiple digital engagement partners, making it challenging to assess the effectiveness of its campaigns.
Recognizing the need for change, the company enlisted Clarkston as its business translator, tasked with breaking down the required steps and executing the client's multi-layered vision. Clarkston was engaged to help the client re-evaluate its spending on digital engagement, with the goal of properly allocating funds to the most effective programs.
Clarkston provided resources and support to internal developers, helping them explain the raw data and organize it effectively. This collaboration led to the design and implementation of an end-to-end digital engagement measurement program that automated data aggregation and analysis across channels, including programmatic display, contextual ads, and paid social media.
The program aimed to increase data visibility by consolidating disparate sources into unified reports. It also enabled contextual data analysis, allowing the company to understand the true impact of its campaigns. As a result, the company was able to allocate marketing spend more effectively, focusing on the highest-performing programs.
Moreover, the program generated internal reports to corroborate and audit vendor-reported metrics for accuracy and accountability. This approach improved transparency and trust in vendor data, leading to better-informed decisions and optimized digital engagement strategies.
Beyond measurement, Clarkston's data and analytics consulting also leveraged advanced platforms and analytics to enhance operational efficiency and patient engagement. Insights from predictive analytics and real-world data helped identify patient segments and tailor engagement efforts, further optimizing resource use and outcomes.
The collaboration between the biopharmaceutical company and Clarkston resulted in the identification of tens of millions of dollars of ineffective spending, significantly benefiting the client's digital measurement capabilities. Clarkston conducted interviews with key stakeholders to align on goals and develop an actionable plan. The company's Product Strategy and Digital Operations teams were then equipped with the tools and information necessary to take ownership of interpreting spend ROI.
In summary, Clarkston's data and analytics consulting services empower biopharmaceutical companies to control and validate their digital engagement data, improve transparency in vendor interactions, and optimize marketing investments by implementing integrated, automated analytics solutions paired with strategic business expertise.
For more information about Clarkston's Data and Analytics Consulting Services, please contact us. This case study showcases the results of Clarkston's successful collaboration with a biopharmaceutical company, demonstrating the transformative impact of effective digital engagement measurement strategies.
- The biopharmaceutical company partnered with Clarkston for assistance in revising its spending on digital engagement, specifically targeting the allocation of funds to the most effective programs.
- Clarkston's support to internal developers led to the creation and execution of an automated digital engagement measurement program, aggregating and analyzing data across diverse channels.
- The program aimed to improve data visibility, consolidate disparate sources, enable contextual data analysis, and optimize marketing spend allocation.
- As a result of the collaboration, Clarkston helped the biopharmaceutical company identify tens of millions of dollars of ineffective spending, enhancing its digital measurement capabilities and operational efficiency.
